BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 32778033)

  • 1. Angiotensin-Converting Enzyme 2 Roles in the Pathogenesis of COVID-19.
    Kenarkoohi A; Maleki M; Safari T; Kaffashian MR; Saljoughi F; Sohrabipour S
    Curr Hypertens Rev; 2021; 17(3):207-216. PubMed ID: 32778033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.
    Hooper NM; Lambert DW; Turner AJ
    Clin Sci (Lond); 2020 Sep; 134(18):2489-2501. PubMed ID: 32990314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
    Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
    Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
    Hrenak J; Simko F
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19: the renin-angiotensin system imbalance hypothesis.
    Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
    Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure.
    Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P
    Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
    Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
    Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage.
    Kirtipal N; Kumar S; Dubey SK; Dwivedi VD; Gireesh Babu K; Malý P; Bharadwaj S
    Infect Genet Evol; 2022 Apr; 99():105254. PubMed ID: 35217145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19.
    Matsuzawa Y; Kimura K; Ogawa H; Tamura K
    Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].
    Cano F; Gajardo M; Freundlich M
    Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
    Brojakowska A; Narula J; Shimony R; Bander J
    J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System.
    Sansoè G; Aragno M
    J Renin Angiotensin Aldosterone Syst; 2023; 2023():3362391. PubMed ID: 37476705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
    Sackin H
    Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
    Tseng YH; Yang RC; Lu TS
    Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
    Steckelings UM; Sumners C
    Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
    Beyerstedt S; Casaro EB; Rangel ÉB
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences.
    Dettlaff-Pokora A; Swierczynski J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
    Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection.
    Sinha A; Vaggu RG; Swain R; Patnaik S
    Curr Microbiol; 2023 Apr; 80(6):194. PubMed ID: 37106165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.